Tag: AV access
DCB vs plain balloon AV access angioplasty: More investigation is needed,...
At the recent Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual meeting (14–18 September, Lisbon, Portugal), Kate Steiner (East and North Herts NHS...
Humacyte ATEV meets primary endpoints in V007 Phase 3 clinical trial...
Humacyte has announced positive top-line results from the V007 Phase 3 clinical trial of the acellular tissue engineered vessel (ATEV) in arteriovenous access for...
New algorithm aims to provide clearer guidance on high AV access...
At the most recent American Society of Diagnostic and Interventional Nephrology (ASDIN) annual scientific meeting (23–25 February 2024, New Orleans, USA), Gerald Beathard (University...
Haemodialysis access session offers routes to improved outcomes for patients
At the 2023 VEITHsymposium (14–18 November, New York, USA), the final day featured a dedicated programme entitled “Improving outcomes in haemodialysis access”, which was...
The FLEX vessel prep system: working to extend time and improve...
This advertorial is sponsored by VentureMed Group.
Arteriovenous (AV) access is challenging and dialysis is hard on the body and the mind. It causes physical...
Renal Interventions’ top 10 stories of March 2023
The month of March brought PAVE-2 updates, preservation debates and an assessment of the best options in marginal veins. A series of transplant updates,...
Preservation or ligation? Post-transplant AV access best practice debated
The Saturday morning session of the American Society of Diagnostic and Interventional Nephrology (ASDIN) 19th Annual Scientific Meeting (17–19 February, Orlando, USA) played host...
Regenerative material found “safe and feasible” as haemodialysis access conduit
Autogenous fistulas offer advantages to haemodialysis patients, long-term survival and low rates of complication among them. But failed or slow maturation as well as...
Precision medicine: The promise of machine learning in dialysis access
Saravanan Balamuthusamy (PPG Healthcare, Fort Worth, USA) writes to assess recent evidence on the contribution that can be made to vascular access for dialysis...
Hypotension and AV access thrombosis: causation or just association?
Aisha Shaikh (Memorial Sloan Kettering Cancer Centre, New York, USA) has staked out a claim that, though hypotension is “associated” with arteriovenous access (AV)...
Not always ‘the alternative’: Are arteriovenous grafts unfairly maligned?
The arteriovenous graft (AVG) for use as a dialysis conduit is a story of innovation, disappointment, intrigue, politics and hope. A recent recalibration of...
Early data indicate benefits of MAGIC in improving cannulation technique
Early data have indicated that a national project, dubbed MAGIC (Managing access by generating improvements in cannulation), has improved cannulation techniques of haemodialysis accesses...
IN.PACT AV DCB sustained “superior” effectiveness in subgroups with high reintervention...
Several subgroups of patients treated with the IN.PACT AV drug-coated balloon (DCB; Medtronic) for arteriovenous fistulas (AVFs) demonstrated a “statistically significant” higher rate of...
First-in-human study of Wrapsody cell-impermeable endoprosthesis yields “very promising” results
Merit Medical Systems has announced positive results from a prospective, observational, first-in-human study to evaluate the safety and effectiveness of Wrapsody—a self-expanding, cell-impermeable endoprosthesis...
More mixed results for DCBs in AV access maintenance as evidence...
Additional randomised controlled data regarding the effectiveness of drug-coated balloons (DCBs) in maintaining arteriovenous (AV) access offers new evidence, but it is freighted with...
Multicentre trial of haemodialysis access strategies in older patients deemed feasible...
A multicentre clinical trial to assess arteriovenous fistula (AVF)-first and arteriovenous graft (AVG)-first access strategies in older end-stage renal disease (ESRD) patients on haemodialysis...
New England Journal Of Medicine publishes “outstanding” six-month IN.PACT AV Access™...
NOTE: This video is ONLY available to watch in selected countries and geographies
Robert Lookstein (New York, USA; principal investigator) and Andrew Holden (Auckland,...
IN.PACT™ AV Access trial shows improvement in patency “for the entire...
A trio of vascular experts including Raphaël Coscas (Paris, France), Alexandros Mallios (Paris, France) and Kate Steiner (Stevenage, UK) discuss the key findings of...